| Industry Range | | Price / Earnings | 0.93 | |
| Book Value | -2.83 | |
| Earnings Per Share | -$1.79 | |
| Price To Sales Ratio | 10.17 | |
| Price To Book Ratio | 4.23 | |
| Price To Tangible Book Ratio | 4.23 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 183.8M | |
| Float (MRQ) | 95.98% | |
| Shares Outstanding (MRQ) | 62.6M | |
| Short Interest as a % of Float (MRQ) | 18.72% | |
| Shares Held By Institutions (MRQ) | 30.3M | |
| Industry Range | | Sales | $79.9M | |
| Gross Margin | 97.11% | |
| Net Profit Margin | -167.35% | |
| EBIT Margin | -144.91% | |
| EBITDA Margin | -143.20% | |
| Operating Margins | -144.91% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 4.79 | |
| Quick Ratio (MRQ) | 4.79 | |
| Total Debt/Equity Ratio (MRQ) | 1,462.74 | |
| Debt/Common Equity Ratio (MRQ) | 1,462.74 | |
| Industry Range | | Return on Equity | 75.62% | |
| Return on Assets | -91.55% | |
| Asset Turnover | 0.55 | |
| Receivables Turnover | 1.80 | |
| Inventory Turnover | 3.20 | |
| Industry Range | | EPS Growth Annual | -228.75% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*OMER does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.21%